Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
NCT05761093 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 306
Last updated 2025-05-06
Summary
The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.
Conditions
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Chi Fai NG, MD · Chinese University of Hong Kong
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-07
- Primary Completion
- 2025-12-31
- Completion
- 2026-03-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
NCT06377124 ·Status: RECRUITING ·Phase: NA
-
Effect of Exercise Therapy on Psychological State and Clinical Prognosis of Advanced Non-small Cell Lung Cancer
NCT05959265 ·Status: UNKNOWN ·Phase: NA
-
Integrative Analysis of Large-cell Lung Cancer
NCT02917369 ·Status: RECRUITING
-
The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population
NCT03893929 ·Status: RECRUITING
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
NCT03413956 ·Status: COMPLETED
-
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
NCT07250360 ·Status: COMPLETED
-
Patient's Whole Process Follow-up Management(HOPE-1)
NCT05339568 ·Status: RECRUITING
-
Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study
NCT06484127 ·Status: COMPLETED
-
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients
NCT05023746 ·Status: COMPLETED
-
Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer
NCT02397239 ·Status: UNKNOWN
-
Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival
NCT07100444 ·Status: COMPLETED
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
Prospective rAndomized sTudy efficaCy tHree-dimensional rEconstructions Segmentectomy
NCT05716815 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214 ·Status: RECRUITING ·Phase: NA
-
Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy
NCT02155426 ·Status: UNKNOWN
-
Development of a Scale for Cancer Patients' Willingness to Voluntarily Participate in Drug Clinical Trials
NCT06120335 ·Status: RECRUITING
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED
-
Postoperative Pulmonary Function Assessment Based on Deep Learning Study
NCT07256457 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735 ·Status: UNKNOWN
-
Needs Assessment to Guide the Development of a Paediatric Survivorship Programme in Hong Kong
NCT05355779 ·Status: COMPLETED
-
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
NCT05721963 ·Status: UNKNOWN
-
Health Outcomes and Costs (HOC) in Lung Cancer (LC)
NCT02363101 ·Status: UNKNOWN
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING